Skip to content

Clinical evaluation of eye-movement perimetry in glaucoma

Clinical evaluation of eye-movement perimetry in glaucoma - Glaucoma screening with eye-movement perimetry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57049
Enrollment
200
Registered
2023-11-10
Start date
2024-01-09
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma POAG

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Control participant: - Visual Acuity (best corrected) 0.30 logMAR (or better) - Age: 18-80 years - Informed written consent Participant with glaucoma: - Diagnosed with glaucoma including glaucomatous visual field loss on SAP - Visual Acuity (best corrected) 0.3 logMAR (or better) - Age: 18-80 - Informed written consent

Exclusion criteria

Exclusion criteria: Control participant: - eye disease (not including glasses or uncomplicated cataract surgery - abnormal OCT - family history of glaucoma (father, mother, brother or sister with glaucoma, or if the person has ever had a high eye pressure measured) - neurological disorder that may influence the visual field or eye movements (such as a stroke, MS or Parkinson*s Disease) Participant with glaucoma: - neurological disorder that may influence the visual field or eye movements

Design outcomes

Primary

MeasureTime frame
Diagnostic performance: sensitivity, specificity, and the area under the receiver-operating characteristic (ROC)-curve of the SONDA and the BulbiCAM The output of the feedback questionnaire for each perimetric technique.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)